An interview with founder & CEO of Axitan – Dr. Kane Miller


Axitan is a brand new biotech corporate that develops non-antibiotic feed additive answers


calendar icon 12 September 2023

clock icon
3 minute learn

Editor’s be aware: Remaining week I stuck up with the founder and CEO of Axitan, Dr. Kane Miller, by way of Zoom. His corporate is keen on growing a library of antimicrobial enzymes, referred to as endolysins, that selectively wreck economically necessary micro organism in animal agriculture. Their first industrial product – referred to as FORC3® – addresses Clostridium perfringens in poultry. Take a look at the interview beneath.

Who’s Axitan?

At its core, Axitan is a biotech corporate that used to be established to expand a non-antibiotic primarily based feed additive approach to cope with problematic micro organism traditionally controlled via antibiotics in animal feed. No longer unusually, our core control crew – myself, Dr Wei Lee (COO) and Dr Francisco Navarro (CSO) – are all scientists from main UK and US establishments. We’re then supported via a extremely skilled Board from the USA agricultural sector and are extremely joyful to have Clint Severson as a industry consultant and shareholder. Clint is possibly best possible identified for reworking Abaxis and exiting it to Zoetis for circa $1.9b in 2018.

What’s your small business center of attention?

Our industry center of attention is the advance of endolysin primarily based answers for:

  1. focused on and destroying micro organism that have an effect on farm animals farming
  2. making improvements to the potency of farm animals manufacturing
See also  Gumboro Illness problem, and the keep watch over

To give an explanation for, an endolysin an antimicrobial enzyme that particularly binds to after which cuts the cellular wall (the peptidoglycan layer) of the centered micro organism, inflicting it to burst.

In order a biotech corporate, we’re within the industry of figuring out one of the best endolysins for focused on any given pathogen and, in parallel, formulating them into merchandise of business relevance.

What explicit issues do you clear up for poultry manufacturers/business?

Inside the poultry business, our first product has been advanced to handle two very common demanding situations integrators let us know they face:

  1. managing Clostridium perfringens in a NAE context extra scientifically and sustainably
  2. the consistent want to make stronger efficiency KPI’s reminiscent of feed conversion and day by day weight acquire, each in “No Antibiotics Ever” and “No Antibiotics Vital to Human Drugs” settings

Species centered/varieties of product(s)?

Our first product is known as FORC3. This is a GRAS-affirmed feed additive particularly for poultry and is typically incorporated into starter and grower feed. Inclusion ranges usually run on the 1lb according to ton stage, it being blended into the feed on the feed mill.

What makes your small business/merchandise distinctive?

With out in need of to overstate it, we’re growing a brand new form of feed additive that may lend a hand form the way forward for the animal feed additive business the world over because it transitions clear of antibiotics and ionophores.

Dr. Kane Miller acquired an Engineering Doctorate (EngD) in Biochemical Engineering from College School London (UCL). He earned his BSc in Mathematical Physics on the College of Nottingham, adopted via a Grasp’s level in Biochemical Engineering at UCL. Kane’s doctoral research keen on algal manufacturing techniques. After graduating, he spent a 12 months as a Postdoctoral Analysis Affiliate the place he investigated the economic packages of algal biotechnology. It used to be all through this time that the idea that of making use of algal biotechnology to animal agriculture got here into center of attention. Because the founding father of Axitan, he’s intently interested in all facets of the industry. While his position has developed, from a bioprocess engineering center of attention at Axitan’s conception, he nonetheless is actively concerned within the clinical, production, and regulatory decision-making procedure. Kane oversees Axitan’s technique and its execution, along with offering steering, control and motivation to the remainder of the crew. He additionally authored and co-authored either one of Axitan’s a success Innovate UK grant proposals and has spearheaded Axitan’s fundraising actions.



Leave a Comment